The Coalition for Imaging & Bioengineering Research is proud to welcome back Steven E. Seltzer, MD, as the Chairman for the Coalition in 2016, along with welcoming Coalition Vice Chairman Richard L. Ehman, MD. This year promises to be another successful campaign for the Coalition after celebrating the establishment of the Interagency Working Group on Medical Imaging (IWGMI) in the President’s Office of Science & Technology Policy, as well as the passing of a $2 billion budget increase for the NIH just a few short months ago. Take a moment to read the message from Coalition Chairman Steven E. Seltzer, and see the overview below of President Obama’s FY2017 budget request to learn more.
Save the Date: 2016 CIBR Medical Technology Showcase – April 12, 2016
The 2016 Medical Technology Showcase is approaching in just a few short months with several collaborative partnerships coming together for the presentation booths as well as academic presenters including the recently announced 2016 Council of Early Career Investigators in Imaging (CECI2) travel awardees. Stop over to the event page for live registration and a preliminary schedule. We encourage all CIBR members to consider registering and attending the Showcase to take full advantage of the opportunity to collaborate with other segments of CIBR membership.
Research Funding and the Importance of Continued Advocacy at the National Institute of Biomedical Imaging and Bioengineering (NIBIB)
The National Institutes of Health (NIH) has received a long overdue $2 billion increase in funding. As we begin to focus on FY17 appropriations, it is important that the imaging community continue to advocate ensuring that the FY16 increase for NIH is the first step in a consistent commitment to capitalize on innovative scientific opportunity.
The NIBIB received a portion of the $2 billion increase in NIH’s appropriated funding in FY16 under the FY16 omnibus reconciliation bill. In total dollars, NIBIB’s budget in FY16 is $343.5 million, up from the FY15 budget amount of $327.2 million. In addition to this increase, NIBIB is receiving $3.6 million for the President’s BRAIN initiative. Read more from Renee Cruea, President, CIBR.
Overview of President Obama’s FY2017 Budget Request
The President’s Fiscal Year 2017 (FY17) budget was released on February 9, including a request for $82.8 billion in discretionary funding for the Department of Health and Human Services (HHS). Within this amount is $33.1 billion to the National Institutes of Health (NIH), nominally $1 billion more than was appropriated to the agency in FY16. However, a keen understanding between discretionary and mandatory funding is required to better understand how this amount is to be prioritized.
NIH and the President’s Research Priorities
The President’s FY17 NIH budget prioritizes a number of the Administration’s initiatives, including:
- Precision Medicine Initiative (PMI)
- National Cancer “Moonshot”
- BRAIN Initiative
- New research processes and priorities related to HIV/AIDS
- Development of equipment and processes for harnessing big data
The President’s budget requested $18.2 billion in total research project grants, which represents a net increase of 600 grants and $385.6 million over FY2016. However, it is worth noting that there is projected to be 628 fewer new grants in FY17. All of the increase is encompassed in noncompeting and SBIR/STTR grants.
The President also requested $2.6 billion in funding for research centers, reflecting a decrease of $55.5 million from FY16. The President requested $641.3 million towards research careers, an increase of $9,049,000 over FY2016. Total research training increased by $18.2 million to $848.6 million for FY17.
Mandatory & Discretionary Funding – What’s the Difference for 2017?
As noted above, when considering both mandatory and discretionary funds, the President’s budget includes a $1.0 billion, or a 3.2% increase in funding for NIH. The quandary is that discretionary funding requires appropriation from Congress, while mandatory funds are permanently appropriated based on statutory language. Members of the Appropriations Committee in the House and Senate have many more and sometimes competing priorities to fund via the use of their jurisdiction over discretionary funds.
What this means is that discretionary appropriations are just the tip of the iceberg and still require a great deal of energy, effort, and advocacy to ensure the most positive outcome for NIH funding which has traditionally almost entirely comprised of discretionary appropriations. Conversely, programs such as Medicare and Social Security are mandatory by law.
The President’s budget designates the $680 million coming to NIH for the Cancer Moonshot as mandatory. It also creates a new line for “Other Mandatory Financing” at $1.15 billion. This total of $1.8 billion in mandatory funding for the NIH suggests that the available funding is really $31.3 billion, not $33.1 billion.
The Academy and CIBR will be very involved in the challenge to advocate for the most positive outcome for a real, bottom line funding increase for imaging – and all – biomedical research.
National Institute of Biomedical Imaging and Bioengineering (NIBIB)
Now to assess the NIBIB budget request more specifically, in his FY2017 budget, the President requests funding for NIBIB at $343.5 million. However $9.5 million of this falls into the “Other Mandatory Financing” category discussed above.
As stated in the President’s budget based on the assumption that the mandatory funding materializes, the budget includes $219.2 million in Research Project Grants; status quo on Research Center funding at $47.2 million and on Training Grants at $10.2 million. Research and Development Contracts increase from $18.3 million to $26.5 million. There are no funds identified in the budget designated as coming from the President’s mandatory cancer moonshot funding.
The President’s budget starts to bring some clarity to the Vice President’s initiative that has become known as the “Cancer Moonshot.” The budget includes approximately $1.0 billion to support this effort. Within this amount there is $755 million in mandatory funds in FY2017 “to accelerate progress in preventing, diagnosing, and treating cancer.” This includes $680 million to NIH and $75 million to the Food and Drug Administration (FDA) for “research and infrastructure,” including efforts to bring researchers across disciplines together to accelerate research and treatment.
The President’s request indicates that $195 million towards new cancer initiatives at NIH during the current fiscal year (FY16). It is not entirely clear where these funds will be allocated from and the Academy will continue to monitor developments to clarify these allocations.
Across HHS, moonshot efforts will include support for the following broad thematic areas:
- Prevention and cancer vaccine development
- Early cancer detection
- Cancer immunotherapy and combination therapy
- Genomic analysis of tumor and surrounding cells
- Enhanced data sharing
- Development of an oncology center of excellence
- Pediatric cancer
CIBR and the Academy will continue working on the development of a cancer centric imaging agenda and will continue consistent communication on our progress.
With the release of the President’s budget begins a process to prioritize and advocate for funding of programs and initiatives that will have the most positive impact on enhancing patient care through advances in biomedical imaging.
New CIBR Members
CIBR members share a common commitment to advancing patient care and medical innovation, and welcome the following new members to the coalition by advocating for consistent and appropriate levels of federal dollars for imaging research.
New Industry Members:
Virtual Imaging, Inc. (a Canon U.S.A. company)
Virtual Imaging, Inc. is a wholly owned subsidiary of Canon U.S.A., Inc. Combining unmatched experience, extensive resources and broad business functions, Virtual Imaging collaborates with large complex hospitals, imaging centers, private physician offices and government organizations to support them in becoming efficient, high-performance healthcare providers and professionals with the latest in digital radiography technology. We assist in the forward advancement of our clients, from strategic planning to day-to-day operations, with our commitment to providing products and services for diagnostic equipment, imaging solutions, and digital flat panel technology.
Get to Know Virtual Imaging, Inc. (VII)
CIBR: What are some exciting new or upcoming research developments from Canon that you would like to share with our research and patient advocacy member’s community at large may not be aware of?
VII: Cone Beam CT for mammography.
CIBR: We understand you plan to participate in the upcoming 2016 Medical Technology Showcase in Washington DC on April 12th. What will your display be focused on and who will you be collaborating with?
VII: Our display will focus Digital Radiography and the Benefits to Patients. Canon will be collaborating with The National Patient Advocate Foundation, Sugar Mommas, and Dr. Min at New York Presbyterian Hospital, Weill Cornell Campus.
CIBR: Aside from your collaborative display, what else are you looking forward to/participating in during your visit?
VII: We are very much looking forward to joining CIBR and meeting with our elected officials to discuss Medical Imaging and the aim of addressing Cost, Quality and Outcomes for patients. We are also looking forward to finding new ways to collaborate and contribute to the CIBR community and healthcare in general.
New Patient Advocacy Organizations:
The Coalition Against Pediatric Pain: The Coalition Against Pediatric Pain is a national non-profit committed to improving the quality of life of children living with chronic pain from rare diseases by: supporting and uniting families affected by pediatric pain, advocating for children in pain by increasing awareness of their needs, educating others regarding their long-term consequences of pediatric pain, funding research dedicated to pediatric pain conditions and providing resources to families and professionals.
International Alliance for Pediatric Stroke: The International Alliance for Pediatric Stroke was established to facilitate collaboration among the many worldwide pediatric stroke communities. Its purpose is to provide leadership for partnerships with global pediatric stroke communities for advancing awareness, knowledge, and research for babies and children who have been impacted by stroke.
Brendon’s Smile: Brendon’s Smile was established following the discovery of a perinatal stroke experienced by the founder’s son. In the process of becoming the World Pediatric Stroke Association, the organization plans to expand its role to help all children with pediatric stroke. The Coalition extends its appreciation to Brendon’s Smile for their participation in the upcoming 2016 Medical Technology Showcase.
Cystic Fibrosis Foundation: The mission of the Cystic Fibrosis Foundation is to cure cystic fibrosis and to provide all people with the disease the opportunity to lead full, productive lives by funding research and drug development, promoting individualized treatment and ensuring access to high-quality, specialized care. The Coalition extends its appreciation to the Cystic Fibrosis Foundation for their participation in the upcoming 2016 Medical Technology Showcase.
Notice Something Different?
Welcome to the new edition of the CIBR member newsletter. To maintain a reference of this resource for all members online and in response to the survey feedback, beginning with this update, we are now publishing newsletter content in full online. Announcements will continue to be sent to you when each new edition of the newsletter is posted online.
The Coalition would also like to thank everyone who participated in our survey, and for their positive feedback on this resource.
What We’re Reading:
Taking Control: Learn More About Accessing Your Health Information: http://directorsblog.nih.gov/2016/01/12/taking-control-learn-more-about-accessing-your-health-information/
Action Plan for Lupus Research: http://www.niams.nih.gov/About_Us/Mission_and_Purpose/action_plan_lupus.pdf
Technologies Enhance Tumor Surgery: https://newsinhealth.nih.gov/issue/Feb2016/Feature1?platform=hootsuite
NIBIB 60 Seconds of Science How Does a PET Scan Work: https://www.youtube.com/watch?v=GHLBcCv4rqk
Registration is now open for the 3rd Annual Human Placenta Project Meeting: Understanding Human Placental Structure and Function in Real Time, Incorporating Novel Technology into the HPP. The meeting will be held on April 14–15, 2016 at Natcher Conference Center, Building 45, NIH Main Campus, 45 Center Drive, Bethesda, MD 20892
Meaningful Use Will Likely End in 2016, CMS Chief Andy Slavitt Says – http://www.healthcareitnews.com/news/andy-slavitt-puts-meaningful-use-ice-read-his-jp-morgan-speech-transcript
President Signs Executive Memorandum on Cancer Moonshot: https://www.whitehouse.gov/the-press-office/2016/01/28/memorandum-white-house-cancer-moonshot-task-force
Vice President Biden Asking Everyone to Share How Cancer has Touched Them https://www.whitehouse.gov/webform/cancer-touches-all-us-share-your-story-here\
FDA Proposes Cybersecurity Guidance for Medical Devices: http://www.reuters.com/article/us-medical-devices-fda-idUSKCN0UT2GE
Recent & Upcoming Awareness Months:
National Pancreatic Cancer Clinical Trials Awareness Month
Birth Defects Prevention Month
Cervical Cancer Awareness Month
Thyroid Awareness Month
Glaucoma Awareness Month
Mental Wellness Month
National pharmacists day (January 12)
Moebius Syndrome Awareness Day (January 24)
National Cancer Prevention Month
Heart Awareness Month
Retinitis Pigmentosa Awareness Month
National AMD and Low Vision Awareness Month
Marfan Awareness Month
Turner Syndrome Awareness Month
Gallbladder and Bile Duct Cancers Awareness Month
Congenital Heart Defect Awareness Week (February 7-14)
Rheumatoid Arthritis Awareness Day (February 2)
National Women’s Physician’s Day (February 3)
World Cancer Day (February 4)
National Wear Red Day for Women and Heart Disease (February 5)
World Cholangiocarcinoma Day (February 17)
National Eating Disorders Awareness Week (February 21-27)
World Rare Disease Day (February 29)